Empirical Treatment for Meningitis in Children and Teenagers
For children aged 1 month to 18 years with suspected bacterial meningitis, initiate empirical treatment with cefotaxime (75 mg/kg every 6-8 hours) or ceftriaxone (50 mg/kg every 12 hours, maximum 2g every 12 hours) PLUS vancomycin (10-15 mg/kg every 6 hours targeting serum trough concentrations of 15-20 μg/mL). 1
Age-Specific Empirical Regimens
Neonates (<1 month old)
- Ampicillin/amoxicillin PLUS cefotaxime (or ampicillin plus an aminoglycoside)
- Age <1 week: cefotaxime 50 mg/kg every 8 hours; ampicillin 50 mg/kg every 8 hours; gentamicin 2.5 mg/kg every 12 hours
- Age 1-4 weeks: ampicillin 50 mg/kg every 6 hours; cefotaxime 50 mg/kg every 6-8 hours; gentamicin 2.5 mg/kg every 8 hours 1
This broader coverage is essential because neonates have a different pathogen spectrum including Group B Streptococcus, Listeria monocytogenes, and gram-negative enteric bacteria.
Children 1 Month to 18 Years
- Third-generation cephalosporin (cefotaxime or ceftriaxone) PLUS vancomycin 1
- The vancomycin component addresses potential penicillin-resistant Streptococcus pneumoniae
- If local resistance patterns show true cephalosporin resistance (MIC >2 mg/L) is unlikely, some experts suggest cephalosporin monotherapy, but dual therapy remains the safest empirical approach 1
Special Consideration: Meningococcal Disease
For children >3 months with suspected invasive meningococcal disease specifically:
- Cefotaxime monotherapy is appropriate 2
- Ceftriaxone may substitute if no calcium-containing parenteral agents used in preceding 48 hours 2
- Treatment duration: 7 days 2
Critical Timing and Administration Points
Do NOT Delay Antibiotics
- Administer antibiotics immediately after blood cultures are drawn
- If lumbar puncture is contraindicated (severely impaired consciousness, focal neurological deficits, new seizures, signs of shock with purpura), give antibiotics first, perform LP later 2
- In meningococcal septicemia without clear meningitis, LP is not recommended initially 2
Adjunctive Dexamethasone
Administer dexamethasone 0.15 mg/kg every 6 hours for 4 days with or within 24 hours of the first antibiotic dose when treating empirical bacterial meningitis of unknown etiology 2. This reduces hearing loss and neurological sequelae, though not mortality 1.
Exception: Do NOT use steroids in meningococcal septicemia unless inotrope-resistant shock is present 2.
Duration of Treatment
- Standard duration: 10-14 days depending on pathogen (once identified) 1
- Culture-negative cases: Continue empirical treatment for minimum 2 weeks 1
- Meningococcal meningitis: 7 days with satisfactory clinical progress 2
The guideline explicitly recommends against short-course therapy (5 days) despite one large RCT showing equivalence, because that study population (primarily Malawi/Pakistan with high H. influenzae rates) differs substantially from European/Western epidemiology 1.
Common Pitfalls to Avoid
Omitting vancomycin: Despite declining cephalosporin-resistant pneumococcal rates, vancomycin should remain part of empirical therapy until susceptibilities are known 3
Delaying antibiotics for imaging: Only obtain CT before LP if there are specific contraindications (impaired consciousness, focal deficits, new seizures); otherwise proceed directly to LP 2
Using ceftriaxone with calcium: Fatal interactions reported in neonates; avoid if calcium-containing solutions used within 48 hours 2
Inadequate vancomycin dosing: Target trough concentrations of 15-20 μg/mL for adequate CSF penetration 1
Forgetting Listeria coverage in neonates: Always include ampicillin/amoxicillin for infants <3 months 2
Regional Resistance Considerations
The choice between cephalosporin monotherapy versus dual therapy with vancomycin depends on local pneumococcal resistance patterns. In areas with reduced penicillin susceptibility or any cephalosporin resistance, dual therapy is mandatory 1. Given the severity of bacterial meningitis and consequences of treatment failure, the conservative approach of dual therapy is recommended unless local surveillance definitively shows no resistance 1.